This review provides a quantitative integration of research on the effectiveness of psychological and pharmacological treatments for nocturnal enuresis. With the use of experiments that compared treatments with either no treatment or another form of treatment, this article assesses (a) the overall effectiveness of psychological arid pharmacological treatments, (b) the relative effectiveness of specific types of treatments, and (c) moderators of treatment effectiveness including investigator allegiance. Findings from the review confirm that enuretic children benefit substantially from treatment. However, more children improve from psychological than from pharmacological interventions. Moreover, psychological treatments involving a urine alarm are most likely to yield benefits that are maintained once treatment has ended.
What to do to correct children's bed-wetting has perplexed professionals and parents since the earliest recorded histories of human society (see review by Glicklich, 1951) . Today, children's bed-wetting continues to be a socially significant problem, and despite several previous reviews, professional consensus about treatment is still lacking (Homsy, 1992; James, 1991; Rappaport, 1993) .
Defined as bed-wetting of at least twice per month in a child 5 years of age or older (American Psychiatric Association [APA], 1987) , nocturnal enuresis is a problem in the development of many children. Although epidemiological estimates of prevalence vary (see review by De Jonge, 1973) , even the most conservative indicate that 7% of all 8-year-old children wet their beds (e.g., Fergusson, Horwood, & Shannon, 1986; Jarvelin, Vikevainen-Tervonen, Moilanen, & Huttunen, 1988) . Fewer than 10% of bed-wetters have any organic complications (American Academy of Pediatrics Committee on Radiology, 1980; Jarvelin, Huttunen, Seppanen, Seppanen, & Moilanen, 1990; Stansfeld, 1973) , so most are called functional entireties. Approximately 80% are termed primary enuretics because they have never attained at least 6 months of continuous nighttime Arthur C. Houts, Jeffrey S. Berman, and Hillel Abramson, Department of Psychology, Memphis State University.
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continence. Secondary or onset enuresis characterizes a minority and has been associated with delayed acquisition of initial nighttime continence as well as a higher incidence of stressful life events (Fergusson, Horwood, & Shannon, 1990; Jarvelin, Moilanen, Vikevainen-Tervonen, & Huttunen, 1990) . Up to the age of 11 years, more than twice as many boys as girls suffer from bed-wetting.
The prevalence of enuresis declines with age, and this decline has contributed to the belief that children will simply outgrow bed-wetting (e.g. Novello & Novello, 1987 ; also see surveys by Haqueetal, 1981; Shelovetal., 1981) . Although most children do eventually stop bed-wetting, cessation without treatment can take several years. For example, Forsythe and Redmond (1974) found that only 15% of 8-year-old children stop bed-wetting in a year if they are not treated, and the annual rate of remission among adolescents is only 16%. As many as 3% of young adults may continue bed-wetting (Forsythe & Redmond, 1974; Levine, 1943; Thorne, 1944) . Considering the social stigma and disruption to family life involved, it is not surprising that continued bed-wetting has been associated with emotional and social problems (Kaffman & Elizur, 1977; Rutter, Yule, & Graham, 1973; Stromgren & Thomsen, 1990 ). In fact, experimental studies have demonstrated that enuretic children treated for bed-wetting improve more than untreated controls on measures of self-concept and peer relations (Baker, 1969; Lovibond, 1964; Moffatt, Kato, & Pless, 1987) .
Current treatments for nocturnal enuresis can be divided broadly into psychological and pharmacological approaches. Approximately 38% of enuretic children are brought to physicians, and 60% of those are treated with pharmacotherapy (Foxman, Valdez, & Brook, 1986) . Although some physicians (e.g., Schmitt, 1982b; Stewart, 1975) have stated that urine alarm treatment is most effective, surveys indicate that physicians recommend this treatment for only 3% of their cases (Foxman et al., 1986; Shelov et al., 1981) . Comparable survey esti-mates for psychologists are not available, but evidence suggests that the theoretical orientation of the mental health practitioner dictates what treatments are advocated (Wagner & Hicks-Jimenez, 1986) .
Since Mowrer and Mowrer (1938) introduced urine alarm treatment, psychological therapies for bed-wetting have been dominated by behavioral procedures (see reviews by Doleys, 1977; Forsythe & Butler, 1989; Johnson, 1980; Lovibond, 1964) . Although controlled research in the 1960s included treatments such as supportive counseling and psychotherapy (De Leon & Mandell, 1966; Werry & Cohrssen, 1965) , most psychological research has been devoted to (a) developing alternative behavioral procedures based on operant conditioning (e.g., Azrin, Sneed, & Foxx, 1974; Azrin & Thienes, 1978) or (b) improving urine alarm treatments within Lovibond's (1963) active avoidance learning formulation (e.g., Fielding, 1980; Finley, Besserman, Bennett, Clapp, & Finley, 1973; .
Following MacLean's (1960) initial report that an incontinent adult treated for depression with imipramine became continent as a side effect, the pharmacological treatment of bedwetting has focused on the use of various tricyclic antidepressants (see reviews by Blackwell & Currah, 1973; Johnson, 1980) . Although other medications such as stimulants, sedatives, anticholenergics, and antispasmodics have occasionally been evaluated experimentally, they are used less often than imipramine (Foxman et al., 1986) . More recently, the synthetic antidiuretic hormone, desmopressin, has also been touted as an effective alternative to both imipramine and the urine alarm.
In general, past reviews of treatments for bed-wetting have focused either on psychological interventions (e.g., Doleys, 1977; Forsythe & Butler, 1989; Lovibond, 1964) or on pharmacological approaches (e.g., Blackwell & Currah, 1973) . In fact, Johnson's (1980) work is the only major review to include both types of treatment, and she highlighted a major methodological problem in comparing the effectiveness of these two approaches. Research on psychological treatments has typically emphasized the cessation of bed-wetting, with results most often reported in terms of the proportion of treated children who attain some cure criterion such as 14 consecutive dry nights (Butler, 1991) . In contrast, research on pharmacotherapies has focused on wetting reduction, with results more likely reported in terms of the frequency of wetting (Evans, 1991) .
In addition to this difference in outcome criteria, comparison among treatments may be further clouded by strongly held allegiances that investigators may have for particular psychological or pharmacological interventions. For instance, the literature on psychological treatment is replete with claims that behavior therapies are superior to psychotherapies (e.g., see Jones, 1960; Lovibond, 1964; and that particular behavior therapies are better than others (e.g., see Azrin & Thienes, 1978; Houts, Peterson, & Whelan, 1986; Marshall, Marshall, & Lyons, 1973; Morgan, 1978) . Similarly, the literature on pharmacological treatments suggests that investigators have generally championed tricyclic antidepressants (e.g., see Dinello & Champelli, 1968; Kass, Diokno, & Montealegre, 1979; Mikkelsen & Rapoport, 1980) , although enthusiasm for other pharmacotherapies such as the antispasmodic, oxybutynin, has not been entirely absent (e.g., see Buttarazzi, 1977) . As in other treatment evaluation situations (e.g., see Berman, Miller, & Massman, 1985; Robinson, Berman, & Neimeyer, 1990) , comparisons of treatments for bed-wetting may therefore be influenced by the allegiance of the investigators conducting the research.
The purpose of the present review was to provide a quantitative summary of controlled evidence concerning the efficacy of psychological and pharmacological treatments for enuresis. In the review, only randomized experiments that contained control or alternative treatment groups were included. Our approach to measuring outcome permitted us to examine both psychological and pharmacological research and to make direct comparisons between different treatments along a common metric. Moreover, because allegiances to particular treatment approaches are evident in this literature, the comparative efficacy of treatments was examined after adjusting for the preference of research investigators.
The following analyses addressed four major questions: First, do children who receive treatment for bed-wetting improve more than children in placebo and no-treatment groups? Second, does the effectiveness of psychological treatments differ from that of pharmacological treatments? Third, are improvements maintained after treatment has ended? Fourth, are there particular types of psychological or pharmacological treatments that are most effective? In addition to assessing these basic questions, we performed analyses to see if the effectiveness of treatments depended on such sample characteristics as the age and gender of the children studied. We also performed analyses to assess whether the effectiveness of treatments depended on characteristics of treatment implementation such as the length of treatment or the period of follow-up.
Method

Treatment and Control Groups
The review is based on results reported for 112 treatment groups and 53 no-treatment or placebo control groups. These groups were drawn from 78 published reports identified through a search of the bibliographies of previous reviews, book chapters, and theoretical articles on enuresis. Searches were also conducted through Index Medicus , Medline (1983 ), Psychological Abstracts (1960 ), and PsycINFO (1974 . Reports were also located through an issue-byissue search of journals that frequently publish investigations of treatments for enuresis. ' Five criteria were used to select treatment and control groups for inclusion. First, only groups drawn from published studies that used random assignment of children to treatment conditions were included. Groups from unpublished dissertations were excluded, as were groups from nonrandomized designs. Second, only treatment and control groups involving ordinary nocturnal enuretic children were included. Groups that provided outcomes exclusively for specialized populations such as mentally retarded enuretic children, adult enuretics, or children who wet only during the day were excluded. Third, only those treatment and control groups that provided quantifiable outcome measures dur-ing the last few weeks of treatment, at posttreatment, or at a followup assessment were included. When neither wetting frequency nor the percentage of children who ceased bed-wetting according to some stated criterion was reported, the group was excluded from the review. Fourth, treatment and control groups drawn from randomized crossover experiments were included only if outcomes were reported separately for each group before the crossover point. When possible carryover effects from these crossover designs could not be determined, the groups were excluded. Fifth, to base estimates of effectiveness on a sufficient number of observations, we excluded treatment groups if there were fewer than four groups receiving a specific type of intervention. This last criterion excluded treatments such as diet modification (Esperanca & Gerrard, 1969) and infrequently used medications such as propantheline (Leys, 1956; Wallace & Forsythe, 1969) and viloxazine (Attenburrow, Stanley, & Holland, 1984) . Also, because there were too few observations on which to base reliable estimates, combinations of pharmacological and behavioral procedures such as stimulants with the urine alarm (Forrester, Stein, & Susser, 1964; Kennedy & Sloop, 1968) ortricyclic medications with supportive psychotherapy (Hagglund & Parkkulainen, 1964) were not included. Occasionally, this criterion led to inclusion of only one treatment or control group from a published study that actually reported results for other groups excluded from our analyses.
Of the 112 active treatment groups examined in the review, 66 (59%) involved psychological techniques without use of medication; the remaining 46 (41%) were based on a pharmacological intervention. Among the 66 psychological treatment groups, 47 (71%) used a urine alarm and 19 (29%) used psychological techniques without a urine alarm. For the 47 urine alarm treatment groups, 28 (60%) used the alarm alone; the other 19 (40%) used an alarm in conjunction with other behavioral procedures (e.g., cleanliness training, dry-bed training, fullspectrum home training, overlearning, and retention control training). Occasionally, investigators described a treatment as "urine alarm alone" when, in fact, the urine alarm was combined with another behavioral procedure. If investigators did not specify that the child was required to remake the bed and perform other aspects of cleanliness training, then we categorized the treatment as urine alarm alone. For example, Geffken, Johnson, and Walker (1986) labeled one of their treatment groups as "urine alarm alone" but reported that this treatment involved having the child remake the bed and change night clothes after a wetting accident. In such instances, we classified the treatment as a case of urine alarm with other behavioral procedures. Of the 19 psychological treatment groups that did not use a urine alarm, 5 (26%) used verbal psychotherapy (e.g., supportive counseling, hypnotherapy) and 14 (74%) used other behavioral treatments (e.g., dry-bed training without an alarm, retention control training).
Among the 46 pharmacological treatment groups, 29 (63%) used a tricyclic antidepressant; 17 (37%) involved another type of medication. Of the 29 tricyclic treatment groups, 20 (69%) used imipramine hydrochloride and the remaining 9 (31%) used other tricyclics (e.g., amitriptyline, desipramine, nortriptyline, protriptyline, trimipramine). Among the 17 treatment groups involving nontricyclic medications, 4 (24%) used desmopressin and 13 (76%) used other medications. These other medication groups consisted of 6 (35%) that used sedatives (e.g., chlordiazepoxide, hydroxyzine, meprobamate, triclofos) and 7 (41%) that used stimulant medications (e.g., amphetamine, ephedrine, methedrine, methylphenidate, phenmetrazine).
Of the 53 control groups examined in the review, 21 (40%) were notreatment controls. The remaining 32 (60%) were placebo control groups, all but one of which used placebo pills. One placebo control group used a nonactivated urine alarm.
Descriptive characteristics of the 165 treatment and control groups are presented in Table 1 . The high proportion of boys and primary enuretics observed in these groups is comparable to proportions generally 1973) . Among groups for which the relevant information was reported, 139 of 163 (85.3%) screened children for medical problems, but only 20 of 158 (12.7%) screened children for psychological problems. Overall, the children that participated in these groups appeared to be representative of enuretic children referred to a clinic (Couchells, Johnson, Carter, & Walker, 1981) .
Estimating Treatment Effects
In general, two types of outcome measures were reported at posttreatment: (a) mean wets in the last week of treatment and (b) the percentage of children who ceased bed-wetting. When reported, the values for wet nights and percentage who ceased bed-wetting were retained separately for posttreatment and follow-up assessments.
The values for these outcome measures were estimated when results were reported in terms of the number of children who fell within categories of improvement. For example, a researcher may have reported that some children achieved between 75% and 100% reduction from the average baseline wetting, whereas other children in the same group attained a reduction between 50% and 74% from baseline. In such cases, the reported figures for the midpoint of each category were weighted by the number of children in the category, and the posttreatment average for the group was then estimated.
Researchers occasionally reported the number of wet nights over the last few weeks of treatment or follow-up. In such cases, the number of wet nights was divided by the number of weeks to determine average wet nights in the last week. When outcomes were reported for multiple follow-up assessments, values for the longest period of follow-up were used. If attrition was greater than 25% at the longest follow-up, values from the next longest follow-up were used.
Given our interest in the relative effectiveness of psychological and pharmacological interventions, these two broad types of treatment were examined for the comparability of outcome measures reported at posttreatment and follow-up. A measure of wetting frequency was reported for most psychological treatments (86%) and for a similar percentage of pharmacological treatments (89%), x 2 0, N = 112) = 0.19, p = .1. In contrast, outcomes reported in terms of cessation were far more commonly reported for psychological treatments (83%) than for pharmacological treatments (54%), x wet nights and percentage who ceased bed-wetting were highly correlated both at posttreatment, r(67) = .87, p < .001, and at follow-up, r([2) = .88, p < .001. The regression analyses yielded the following equations.
Percentage ceased at posttreatment = 83.7 -15.8 (wet nights at posttreatment) (1) Percentage ceased at follow-up = 85.6 -18.6 (wet nights at follow-up) (2) These equations were used to obtain predicted values for percentage ceased bed-wetting for those groups in which outcome was originally expressed in terms of frequency of wetting. Combined with cases in which the percentage who ceased bed-wetting was originally reported, these predicted values were used in all our analyses of treatment effects. 
Investigator Allegiance
Findings from past reviews suggest that, when treatments are compared with one another, the preference or allegiance of the investigator may have a substantial impact on the outcome of the comparison (e.g., Herman et al., 1985; Robinson et al., 1990 ; also see Smith, Glass, & Miller, 1980, chap. 5) . Moreover, treatment effects have been observed to be greatly diminished when a treatment is not the focus of the researcher's attention (e.g., Greenberg, Bornstein, Greenberg, & Fisher, 1992) . To adjust for such allegiance processes, two of the authors examined the introductions of each experiment and independently rated the investigators' allegiance to each active treatment in the experiment. Raters read the introductory section of each experiment and attended to such cues as (a) explicit hypotheses about the relative efficacy of different treatments, (b) the relative level of detail provided for some treatments as opposed to others, and (c) the overall balance of the investigators' attitude toward different treatments. The raters judged the overall level of preference that investigators expressed for a treatment on a 7-point scale that ranged from neutral (1) to extremely favors (7). Given the level of interrater reliability for the average of the two raters, intraclass R = .79, the judgments of the rates were combined to form a mean allegiance score for each treatment group.
Preliminary Analyses
In many quantitative reviews, multiple measures are obtained from the same investigation, raising issues concerning the statistical independence of the observations. Recognizing this potential problem of nonindependence, some researchers have carried out preliminary analyses to determine whether multiple observations from the same study can be treated as statistically independent (e.g., see Casey & Herman, 1985; Robinson et al., 1990 ; also see Glass, McGaw, & Smith, 1981, chap. 6) . In this review, most of the experiments provided outcomes for more than one treatment or control group (M = 2.1 groups, range, 1-4). To examine possible nonindependence in our data, we conducted an analysis of variance in which the unit of analysis was the outcome for each group and the independent variable was the experiment from which the groups were drawn. This analysis failed to indicate that the variability of outcomes between experiments was reliably greater than the variability of outcomes within an experiment at either posttreatment, F(71,81) = 1.09, p = .35, or follow-up, F(43,41) = 1.29, p = .21. Thus, outcomes for different types of treatment within the same experiment were treated as independent, and our analyses were performed using each type of treatment group within an experiment as a separate observation.
As indicated in Table 1 , the number of children in the treatment and control groups varied substantially. On purely statistical grounds, one may expect that there would he more variability in estimates of treatment outcome among groups with small samples than among groups based on larger numbers <>l children. If such a pattern occurs, estimates of treatment outcome would be more accurately represented by weighting the estimates according to sample size. To assess this issue in our data, we conducted a regression analysis in which the sample size of each group was used to predict percentage ceased bed-wetting. We then correlated the squared residuals or errors from this regression analysis with the number of children in a group (e.g., see Robinson etal., 1990) . This analysis failed to indicate that outcomes from the large sample groups were any more precise than outcomes observed from groups with smaller samples. In fact, groups with larger samples actually tended to have greater variability in treatment outcome at both posttreatment, K152) = .16,/7 = .05, and follow-up, r(84) = .32,p = .003. Given these findings, we chose not to weight by sample size but to give each of the groups equal weight in the following analyses. Table 2 presents the mean percentage of children who ceased bed-wetting at posttreatment and follow-up for different types of treatment and control groups. As can be seen, children who underwent either psychological or pharmacological interventions were more likely to have ceased bed-wetting by the end of treatment than were children who received placebos or had no treatment. At the time of a follow-up assessment, cessation of bed-wetting remained substantially higher for children undergoing a psychological treatment than for children in either type of control group. Cessation rates at follow-up were also higher for pharmacological interventions than for controls; however, this difference was not statistically significant in comparison with children who received a placebo.
Although both psychological and pharmacological interventions had outcomes superior to those observed in control groups, children receiving psychological treatments were more likely to have ceased bed-wetting at posttreatment and followup than children given pharmacological treatments. To examine such differences among interventions more closely, we compared the effects of five major types of treatment: (a) psychological treatments with a urine alarm, (b) psychological treatments without a urine alarm, (c) tricyclic medications, (d) desmopressin, and (e) other medications. One issue in conducting such 2 We also performed all analyses on (a) only the subset of observations for which values for wet nights were directly reported, (b) only the subset of observations for which the percentage who ceased bed-wetting was reported, and (c) wet nights for all cases, using a regression analysis to predict wet nights for those cases in which only cessation rates were reported. For all these analyses, the overall pattern of findings was comparable with the results using original and predicted values for cessation.
3 With the exception of scores for control groups, percentages of children who ceased bed-wetting were typically in the range of 25% to 75%, so the reported analyses were conducted on the raw percentages (e.g., see Cohen & Cohen, 1975, section 6.5.5) . We also replicated all our analyses on an arcsine transformation of the cessation percentages, using the value of l/(4«) for zero percentages and (n -l/4)/« for 100% scores (see Snedecor & Cochran, 1980, section 15.12) . The pattern of results from analysis of the arcsine transformed values was consistent with the pattern observed with the raw scores. comparisons is that researchers can have varying degrees of enthusiasm or allegiance to treatments, and such allegiances may affect comparisons of relative efficacy (e.g., Berman et al., 1985; Robinson et al., 1990) . Using our rating of investigator allegiance, we found that the five types of treatment varied systematically in terms of the degree to which researchers favored the interventions, F(4, 107)= 13.14, p< .001. Moreover, the rating of investigator allegiance predicted the percentage of children in a treatment group who ceased bed-wetting at posttreatment, K102) = .49,p< .001, and at follow-up, K60) = .59,p < .001. To control for the possible influence of investigator allegiance, we therefore compared outcomes among the treatments, using the rating of investigator allegiance as a covariate. The cessation rates from these allegiance-adjusted analyses are presented in the right-hand column of Table 3 . As can be seen, children treated with a urine alarm or desmopressin are more likely to have ceased bed-wetting by the end of treatment than children receiving the other three types of treatment. At followup, however, children treated with a urine alarm have outcomes superior both to children receiving desmopressin and to those undergoing any of the other treatments.
We also performed additional analyses to assess differences in the effectiveness of specific subcategories of the major treatment types. Our chief interest was in the relative effectiveness of imipramine, the most widely used tricyclic medication, compared with other tricyclics and the relative effectiveness of basic urine alarm treatment compared with urine alarm treatment combined with additional behavioral procedures. However, our analysis of the allegiance-adjusted means reported in Tables 4  and 5 failed to reveal statistically significant differences between subcategories within any of the treatment types. In particular, there were no reliable differences in efficacy at either posttreatment or follow-up between imipramine and other tricyclic medications or between basic urine alarm treatment and urine alarm treatment combined with other behavioral procedures. 'Means adjusted for investigator allegiance. Adjusted means with different subscripts at posttreatment and adjusted means with different subscripts at follow-up differ reliably (p < .05) from one another. Tests from the analysis of covariance were based on pooled MS, = 465.9 (df = 97) at posttreatment and pooled MS e = 366.9 (rf/= 55) at follow-up.
To examine possible moderators of treatment efficacy, we correlated relevant child and treatment characteristics with the percentage of children who ceased bed-wetting at posttreatment and follow-up. As can be seen from Table 6 , success rates were lower for children who wet more often before treatment or wet • Means adjusted for investigator allegiance. Adjusted means within each treatment category did not differ reliably from one another (ps > .3). The analysis of covariance involved a hierarchical design in which treatment subcategories were nested within treatment categories. Tests were based on pooled MS, = 472.7 (df= 93). during the day as well as at night. In addition, the percentage of children who had ceased bed-wetting at the end of treatment was higher when the treatment was longer or the number of professional contacts was greater. Finally, cessation rates at followup were higher when either the follow-up period in the study was longer or the researchers allowed a larger number of wet nights to define a relapse. Although outcomes were generally better when treatment was longer, further analysis revealed that this relation varied depending on the type of treatment. For example, the longer children were treated with a urine alarm, the higher the rates were for cessation of bed-wetting, r(40) = .54, p < .001. In contrast, the longer children were treated with tricyclic medications, the lower the rates of cessation were, r(26) = -.47, p < .01. For the other three types of treatment, correlations between length of treatment and outcome were not statistically significant (ps>.5).
Discussion
Our analyses demonstrate that enuretic children who receive either psychological or pharmacological treatments are more likely to cease bed-wetting than are children who go untreated. Moreover, the analysis of the untreated control groups suggests that fewer than 1 of every 10 clinic-referred children can be expected to cease bed-wetting as quickly if left untreated. On the basis of this evidence, health care professionals can justifiably advise parents to seek treatment for their enuretic child rather than follow the all-too-popular counsel to wait for their child to outgrow the problem. This advice to seek treatment is all the more important in light of evidence that continued bedwetting is associated with increased problems of social and emotional adjustment (e.g., see review by Moffatt, 1989) .
The results of this review indicate that psychological treatments are generally more effective than pharmacological treatments. In particular, our analyses emphasize that a urine alarm treatment is superior to any other type of intervention. In fact, at follow-up children treated with a urine alarm were almost twice as likely to have ceased bed-wetting than were children who received other treatments. At the same time, our results fail to support claims that adding behavioral procedures to the urine alarm improve its overall effectiveness. Nevertheless, we are reluctant to dismiss the idea of supplementing urine alarm treatments with additional procedures, particularly procedures such as intermittent alarm presentations and forced drinking before bedtime that have been shown in some studies to reduce the rate of relapse (see review by Morgan, 1978) . In the case of these two specific additions to basic urine alarm treatment, we simply had too few observations from which to draw reliable statistical inferences.
Psychological treatments with a urine alarm were administered for longer periods of time than any of the pharmacological treatments. Advocates of pharmacological treatments may contend that, had those treatments been implemented for equal durations, then the relative superiority of urine alarm treatments would disappear. However, when we examined the relationships between length of treatment and outcome in greater detail, we found that the outcome for children who received tricyclic medications actually grew worse the longer they took these medications. Along with previous reports about the potential cardiotoxic effects of imipramine overdose (Herson, Schmitt, & Rumack, 1979; Parkin & Fraser, 1972) , this new finding raises serious questions about the widespread use of imipramine to treat enuresis.
Whereas evidence from this review indicates that enuretic children will benefit from treatment, the findings undermine the common health care practice of first treating enuretic children with medications rather than with a urine alarm. In this regard, it is instructive to highlight a methodological difference that we observed between studies evaluating psychological and pharmacological interventions. Compared with studies assessing psychological treatments, studies examining pharmacotherapies were less likely to have outcome reported in terms of the percentage of children who ceased bed-wetting. This difference in the choice of outcome measures may reflect an underlying difference in goals between pharmacological and psychological treatments for bed-wetting. Advocates of pharmacotherapies have tended to emphasize management rather than cure as a goal of treatment. If the basic goal of treatment is management of bed-wetting, it makes some sense to report outcomes in terms of reductions of wetting frequency. In contrast, if the basic goal of treatment is cure rather than management, then what matters most is the percentage of children who cease bed-wetting over the long term.
Our analyses illustrate a way in which outcomes reported in terms of wetting frequency can be expressed in terms of the percentage of children who cease bed-wetting. This is a methodological advance over previous reviews (e.g., Forsythe & Butler, 1989; Johnson, 1980) , which have been limited by the lack of a comparable metric on which to compare the effects of different treatments. Our approach provides an empirical resolution to the problem of inconsistent definitions in this literature (e.g., see review by Butler, 1991) . We also show that regardless of how one measures the effectiveness of these treatments, psychological treatments with a urine alarm are superior to all others in the long term. Thus, urine alarm treatments should not only be considered the treatment of choice, but the evidence from this review suggests that cure rather than management is a realistic goal for a majority of children suffering from nocturnal enuresis. In this regard, our finding that a psychological treatment is most likely to produce a cure for a problem typically treated by physicians is unusual. Cure is a term more often associated with medical treatment than with psychological therapy, and psychologists have correctly noted that management is a more realistic goal for many of the conditions they treat (e.g., Kendall, 1989) . At least for a substantial number of children, the problem of enuresis appears to be a striking exception.
Overall, we found two child characteristics that were systematically related to treatment outcome. Children who wet less frequently before treatment and children who wet only at night tended to have a better prognosis. The finding of better outcomes for children who wet only at night is consistent with previous suggestions that diurnal enuresis may be indicative of underlying physiological abnormalities that are not likely to be corrected by most treatments used for simple bed-wetting (Fielding, 1980 (Fielding, , 1982 Jarvelinetal., 1990; Schmitt, 1982a) . At the very least, researchers and practitioners should take care to distinguish simple bed-wetting from bed-wetting complicated by diurnal enuresis. On the other hand, our analyses revealed no evidence that child characteristics such as age, gender, or type of enuresis (primary versus secondary) moderated treatment efficacy.
Because of the quantitative focus of our review, there were issues regarding treatment failure and relapse that we could not address directly but that deserve some mention. Previous reviewers (e.g., Doleys, 1977; Johnson, 1980) have noted that a majority of those children who fail to cease bed-wetting with urine alarm treatment can be classified as failures to comply fully with the treatment. We were surprised to find that few of the studies we reviewed used any form of psychological assessment to screen children for inclusion. The feasibility of using psychological measures to predict premature termination from urine alarm treatments has been demonstrated in several uncontrolled investigations not included in this review (Devlin & O'Cathian, 1990; Dische, Yule, Corbett, & Hand, 1983; Morgan & Young, 1975; Wagner & Johnson, 1988) . More extensive use of personality and behavioral assessment by researchers is needed to identify predictors of and reasons for noncompliance (see review by Fielding & Doleys, 1988) .
As our analyses confirm, not all children who cease bed-wetting with urine alarm treatments maintain their treatment gains. In terms of both measurement and treatment, relapse continues to be a problem even for the best interventions. Because too few studies reported relapse rates in a uniform manner that included separate analyses for children who were retreated, we elected to estimate the effectiveness of treatments separately for posttreatment and follow-up. We agree with Butler (1991) that simple reporting of the proportion of children who relapse is a misleading measure. In our view, a more informative measure of a treatment's durability is the percentage of children who cease bed-wetting in the long term. How best to identify the causes of relapse and minimize its occurrence remains a major issue in the treatment of enuresis.
